Reference SummaryAyanga B, Genes Chromosomes Cancer 2006 Jul;45(7):668-75
Title |
Genetic mapping of a putative tumor suppressor locus that influences tumorigenesis and metastasis in mice. |
Authors |
Ayanga B; Price R; Gu X; Lozano G; Evans SC |
Journal |
Genes Chromosomes Cancer |
Volume |
45 |
Issue |
7 |
Year |
2006 |
Pages |
668-75 |
Abstract |
The tumor suppressor TP53 is mutated in approximately 70% of Li-Fraumeni syndrome (LFS) families; however, other genes may lead to the predisposition to tumors in other families. We developed a mouse model to search for other tumor suppressors that may be involved in the syndrome. Inbred CE/J mice, which succumb to multiple types of tumors similar to those found in LFS, were crossed with the Trp53-null 129-Trp53tm1Tyj mouse. We monitored the tumor onset and type and found a significant earlier tumor onset in the CE/J:129-Trp53tm1Tyj mice compared with 129-Trp53tm1Tyj mice with a Trp53-null allele. Additionally, in CE/J:129-Trp53tm1Tyj-Trp53+/- mice, the tumors metastasize, which does not occur in other strains of mice. Using simple-sequence length polymorphism analysis for loss of heterozygosity in tumors, we identified a putative tumor suppressor locus within 1 cM on mouse chromosome 11, which encompasses 12 mapped genes. |
Links |
J:108788 – MGI References 16586494 – National Library of Medicine/PubMed |
| |
| Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
|---|---|---|---|---|---|
| CE129F2-Trp53tm1Tyj | Blood vessel hemangioma | Blood vessel |
1.9 |
||
| CE129F2-Trp53tm1Tyj/+ | Blood vessel hemangioma | Blood vessel |
4.2 |
||
| CE129F2-Trp53tm1Tyj | Blood vessel hemangiosarcoma | Blood vessel |
22 |
||
| CE129F2-Trp53tm1Tyj/+ | Blood vessel hemangiosarcoma | Blood vessel |
7.0 |
||
| CE129F2-Trp53tm1Tyj/+ | Bone osteosarcoma | Bone |
11 |
||
| CE129F2-Trp53tm1Tyj | Connective tissue - Fibroblast fibrosarcoma | Connective tissue - Fibroblast |
7.4 |
||
| CE129F2-Trp53tm1Tyj/+ | Connective tissue - Fibroblast fibrosarcoma | Connective tissue - Fibroblast |
7.0 |
||
| CE129F2-Trp53tm1Tyj/+ | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell tumor | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell |
1.4 |
||
| CE129F2-Trp53tm1Tyj/+ | Leukocyte - Myelocyte (Granulocyte) leukemia | Leukocyte - Myelocyte (Granulocyte) |
1.4 |
||
| CE129F2-Trp53tm1Tyj | Leukocyte lymphoma | Leukocyte |
63 |
||
| CE129F2-Trp53tm1Tyj | Leukocyte lymphoma | Thymus |
52 |
||
| CE129F2-Trp53tm1Tyj/+ | Leukocyte lymphoma | Leukocyte |
14 |
||
| CE129F2-Trp53tm1Tyj/+ | Liver hepatoma | Liver |
13 |
||
| CE129F2-Trp53tm1Tyj/+ | Lung carcinoma | Lung |
1.4 |
||
| CE129F2-Trp53tm1Tyj/+ | Mammary gland carcinoma | Mammary gland |
1.4 |
||
| CE129F2-Trp53tm1Tyj | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
31 |
||
| CE129F2-Trp53tm1Tyj/+ | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
32 |
||
| CE129F2-Trp53tm1Tyj/+ | Muscle - Smooth leiomyosarcoma | Muscle - Smooth |
1.4 |
||
| CE129F2-Trp53tm1Tyj | Muscle - Striated - Skeletal rhabdomyosarcoma | Muscle - Striated - Skeletal |
1.9 |
||
| CE129F2-Trp53tm1Tyj/+ | Muscle - Striated - Skeletal rhabdomyosarcoma | Muscle - Striated - Skeletal |
2.8 |
||
| CE129F2-Trp53tm1Tyj/+ | Ovary carcinoma | Ovary |
1.4 |
||
| CE129F2-Trp53tm1Tyj | Ovary hyperplasia | Ovary |
3.7 |
||
| CE129F2-Trp53tm1Tyj/+ | Ovary hyperplasia | Ovary |
7.0 |
||
| CE129F2-Trp53tm1Tyj/+ | Preputial gland (male) hyperplasia | Preputial gland (male) |
observed |
||
| CE129F2-Trp53tm1Tyj/+ | Sertoli cell (sex not specified) tumor | Sertoli cell (sex not specified) |
1.4 |
||
| CE129F2-Trp53tm1Tyj/+ | Uterus - Endometrium hyperplasia | Uterus - Endometrium |
31 |
||
| CE129F2-Trp53tm1Tyj/+ | (Unspecified organ) adenocarcinoma - cystic | (Unspecified organ) |
1.4 |
||
| CE129F2-Trp53tm1Tyj/+ | (Unspecified organ) adenoma | (Unspecified organ) |
9.9 |
||
| CE129F2-Trp53tm1Tyj/+ | (Unspecified organ) cyst | (Unspecified organ) |
8.5 |
||
| CE129F2-Trp53tm1Tyj/+ | (Unspecified organ) squamous cell carcinoma | (Unspecified organ) |
1.4 |
||
| CE/J | (Unspecified organ) tumor | (Unspecified organ) |
33 |
||
| 129-Trp53tm1Tyj/J | (Unspecified organ) tumor | (Unspecified organ) |
57 |
||
| 129-Trp53tm1Tyj/J | (Unspecified organ) tumor | (Unspecified organ) |
100 |
||
| CE129F2-Trp53tm1Tyj | (Unspecified organ) tumor | (Unspecified organ) |
98 |
||
| CE129F1-Trp53tm1Tyj/+ | (Unspecified organ) tumor | (Unspecified organ) |
100 |
||
| CE129F2-Trp53tm1Tyj/+ | (Unspecified organ) tumor | (Unspecified organ) |
100 |